Immune Therapeutics, Inc. Stock Other OTC
Equities
IMUN
US45252A1079
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.11M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net Debt 2022 | 546K | Net Debt 2023 | 1.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-6
x | P/E ratio 2023 |
-3.65
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.42% |
Managers | Title | Age | Since |
---|---|---|---|
Noreen Griffin
FOU | Founder | 71 | 93-12-01 |
Glen A. Farmer
DFI | Director of Finance/CFO | 55 | 22-08-01 |
Fengping Shan
CTO | Chief Tech/Sci/R&D Officer | 65 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fengping Shan
CTO | Chief Tech/Sci/R&D Officer | 65 | 13-02-28 |
Mary Caperton
BRD | Director/Board Member | 62 | 23-10-23 |
Roger Suro
BRD | Director/Board Member | 50 | Nov. 07 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |